Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TALWIN 50

PENTAZOCINE HYDROCHLORIDE

Standard Dose
EQ 50MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview TALWIN 50 is listed in Drugs@FDA under application 016732 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient PENTAZOCINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1982-04-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview TALWIN 50 is listed in Drugs@FDA under application 016732 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PENTAZOCINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1982-04-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.